Strategies for addressing a broader definition of conflicts of interest

JAMA - Journal of the American Medical Association

Volumn 317, Issue 17, 2017, Pages 1727-1728

  McKinney, Ross E ^a,b   Pierce, Heather H ^a  

^a ASSOCIATION OF AMERICAN MEDICAL COLLEGES   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSTATISTICS; CONFLICT OF INTEREST; DECISION MAKING; FINANCIAL MANAGEMENT; HUMAN; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SAMPLE SIZE; SHORT SURVEY; ECONOMICS; ETHICS; FACTUAL DATABASE; INTERPERSONAL COMMUNICATION; PEER REVIEW; PERSONNEL; PUBLISHING; STATISTICAL ANALYSIS;

BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; DISCLOSURE; JUDGMENT; PEER REVIEW; PUBLICATION BIAS; RESEARCH PERSONNEL;

EID: 85019427983     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2017.3857     Document Type: Short Survey

References (8)

1. Thompson DF. Understanding financial conflicts of interest. N Engl J Med. 1993;329(8):573-576.
2. Als-Nielsen B, ChenW, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events? JAMA. 2003;290(7): 921-928.
3. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-260.
4. Ornstein C, Jones RG, Tigas M. Now there's proof: docs who get company cash tend to prescribe more brand-name meds. ProPublica March 17, 2016. http://www.propublica.org/article/doctors-who-take-company-cash-tend-to-prescribe-more-brand-name-drugs. Accessed March 15, 2017.
5. DeJong C, Aguilar T, Tseng C-W, Lin GA, BoscardinWJ, Dudley RA. Pharmaceutical industry-sponsored meals and physician prescribing patterns for Medicare beneficiaries. JAMA Intern Med. 2016;176(8):1114-10.
6. Centers for Medicare & Medicaid Services. The Facts on Open Payments. https://openpaymentsdata.cms.gov. Accessed April 5, 1017.
7. US Department of Health and Human Services. Responsibility of applicants for promoting objectivity in research for which Public Health Service funding is sought. 42 CFR Part 50 Subpart F. Effective August 24, 2012. https://grants.nih.gov/grants/policy/coi/fcoi-final-rule.pdf. Accessed April 4, 2017.
8. Ioannidis JPA. Acknowledging and overcoming nonreproducibility in basic and preclinical research. JAMA. 2017;317(10):1019-1020.